Vertex Pharmaceuticals Inc (VRTX)

219.39 -1.71  -0.77% NASDAQ Apr 16, 20:00 USD
View Full Chart
Price Chart
View All VRTX News

News

View All Events

Events

Date Type Description
04/29/2020 17:00 EDT Earnings Calls Q1 2020 Earnings Call
04/29/2020 00:00 Earnings Results Q1 2020 Earnings Results
06/03/2020 09:30 EDT Agm 2019 Annual General Meeting
07/30/2020 17:30 EDT Earnings Calls Q2 2020 Earnings Call
07/30/2020 00:00 Earnings Results Q2 2020 Earnings Results
10/29/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/29/2020 16:30 EDT Earnings Calls Q3 2020 Earnings Call
02/01/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/01/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
04/29/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Vertex Pharmaceuticals Inc discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. The company's pipeline also includes genetic therapies like CTX001 for beta-thalassemia and sickle-cell disease as well as small-molecule medicines targeting diseases associated with alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease. In addition, Vertex is focusing on developing therapies for pain, type 1 diabetes, inflammatory diseases, influenza, and other rare diseases.
  • URL: https://www.vrtx.com
  • Investor Relations URL: https://investors.vrtx.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Apr. 29, 2021
  • Last Earnings Release: Feb. 01, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
LMPFX ClearBridge Aggressive Growth FI 4.75%
IBB iShares Nasdaq Biotechnology ETF 4.72%
FBIOX Fidelity® Select Biotechnology 4.53%
ARKG ARK Genomic Revolution ETF 3.95%
FBT First Trust NYSE Arca Biotech ETF 3.54%
ABPRX AB Large Cap Growth R 2.85%
THISX T. Rowe Price Health Sciences I 2.73%
VGHCX Vanguard Health Care Inv 2.03%
USMV iShares MSCI USA Min Vol Factor ETF 1.41%
XLV Health Care Select Sector SPDR® ETF 1.25%
VHT Vanguard Health Care ETF 1.04%
VHCIX Vanguard Health Care Index Admiral 1.03%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.